Bain Capital Life Sciences Investors, LLC Q1 2018 Filing

Filed May 15, 2018

Portfolio Value

$169.6B

Holdings

4

Report Date

Q1 2018

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
8,930,237$85.4B50.34%
2
IFRXINFLARX NV
1,876,413$54.1B31.91%
3
—MARINUS PHARMACEUTICALS INC
3,977,453$15.2B8.96%
4
SLDBSOLID BIOSCIENCES INC
1,989,444$14.9B8.80%